Icon

PERFOROMIST (nda022007)- (0.02MG/2ML)

FORMOTEROL FUMARATE MYLAN SPECLT
0.02MG/2ML
Yes Yes
2021-Jun-22 Expired
None None
None No
PERFOROMIST Inhalation Solution is a long-acting beta2-adrenergic agonist (beta2-agonist) indicated for: • Long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
8 0 7
Total Other Developers 24
Drugs with Suitability No
0.02MG/2ML ** ** - - 6
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** ****** *** *** ****** ********** ******* *********** ***** **** *****, ********** **** ********** ******, ******* *****, *******, ******** *** ***, ****** ******* (***) ***
****** ******* ******** ****************** **** *********** **********., ********-******, - *****, ******* (***) ***
****** ******** ****** *** ******** ****************** **** *********** **********., ********-******, - *****, ******* (***) ***
****** ******* ****** ******* ****** ******* *********** ****-***, ******* *****, ****** **** ****, ***. ****** *******, ****** *****, *******, ******** ******* ******, ***** (***) ***
****** ***** **** ***** **** ******* *********** ***-***, ** *****, ****** **** ****, *****, *********** ********** ****, *********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.